Related Experiment Videos
Biological basis for chemohormonal therapy for prostatic cancer
Cancer Treatment and Research
|January 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
LSD1 inhibition suppresses ASCL1 and de-represses YAP1 to drive potent activity against neuroendocrine prostate cancer.
bioRxiv : the preprint server for biology·2024
Caregivers' perception of adults with Down syndrome willingness to participate in research.
Journal of intellectual disability research : JIDR·2022
Role of α- and β-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic disease.
Cell communication and signaling : CCS·2021
Caspase control: protagonists of cancer cell apoptosis.
Experimental oncology·2012
Assessment of mitochondrial respiratory chain function in hyperphenylalaninaemia.
Journal of inherited metabolic disease·2009
Clinical Trials and Translational Advances in Metabolic Targeting.
Cancer treatment and research·2026
Tools and Technologies for Studying Cancer Metabolism.
Cancer treatment and research·2026
Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.
Cancer treatment and research·2026
Biomarkers of Cancer Metabolism and Therapeutic Response.
Cancer treatment and research·2026
Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.
Cancer treatment and research·2026
Metabolic Reprogramming in Cancer Stem Cells.
Cancer treatment and research·2026
Environmental Endocrine Disruptors Activate CBX2 to Disrupt Cholesterol Homeostasis in PCOS.
The Journal of steroid biochemistry and molecular biology·2026